How the Foot Is Affected in Parkinson’s Disease

Parkinson’s disease (PD) is best known for the cardinal motor features of tremor, rigidity, bradykinesia, and postural instability, and public attention tends to focus on the hands and face — the resting tremor of the fingers, the reduced facial expressivity known as hypomimia. Yet the feet, as the body’s primary contact point with the ground and the foundation of gait, are profoundly affected by the disease in ways that are often underappreciated. Foot-related changes in Parkinson’s disease span motor control, muscle tone, sensory processing, and even skin and circulatory function, and together they contribute significantly to disability, fall risk, and reduced quality of life.

Gait Disturbance and the Mechanics of Walking

The most visible foot-related consequence of Parkinson’s disease is its effect on gait. Bradykinesia — the generalized slowness of movement — reduces stride length and the height to which the foot is lifted during the swing phase of walking. This produces the characteristic shuffling gait seen in many people with PD, in which the feet barely clear the floor and steps become short and quick. Because the toes may not clear the ground adequately, people with Parkinson’s disease are prone to catching their foot on uneven surfaces, rugs, or thresholds, which increases the risk of trips and falls.

A related and particularly disruptive phenomenon is festination, in which steps become progressively faster and shorter, sometimes causing the person to feel as though they are chasing their own center of gravity forward. This can end in a fall if the person cannot bring their feet back under their body in time. Even more disabling is freezing of gait (FOG), a sudden and transient inability to produce effective forward stepping despite the intention to walk. During a freezing episode, a person’s feet may feel as though they are glued to the floor. Freezing is especially common when initiating gait, turning, approaching doorways or narrow spaces, or under stress or dual-tasking conditions (such as walking while talking). Freezing of gait is one of the leading causes of falls in Parkinson’s disease and does not always respond well to standard dopaminergic medication, making it one of the most challenging symptoms to manage.

Rigidity, Dystonia, and Abnormal Foot Posturing

Rigidity — increased resistance to passive movement of a limb — can affect the ankle and foot, contributing to stiffness that alters the normal push-off and heel-strike mechanics of walking. In some individuals, particularly younger-onset patients or those in the “off” state between medication doses, the foot can develop dystonia, an involuntary sustained muscle contraction that produces abnormal postures. A well-recognized presentation is “striatal toe” or foot dystonia, in which the big toe extends upward (dorsiflexes) involuntarily while the other toes may curl downward, or the entire foot inverts and the ankle plantarflexes into a clenched, cramped position. This can be painful and can make it difficult to fit the foot properly into shoes, sometimes forcing changes in footwear or requiring orthotic devices. Foot dystonia in PD often fluctuates with medication timing, tending to appear as levodopa levels dip in the early morning or as a dose wears off, which is a useful clue for clinicians adjusting medication schedules.

Dyskinesia and Involuntary Movement

On the opposite end of the motor spectrum, long-term use of levodopa can lead to dyskinesias — involuntary, often writhing or jerky movements — which may involve the foot and toes as part of a broader limb pattern. Choreiform dyskinesias affecting the leg and foot can interfere with balance and add an additional element of unpredictability to gait, distinct from the stiffness of dystonia but similarly disruptive to normal foot function.

Sensory and Proprioceptive Changes

Parkinson’s disease is not purely a motor disorder; it also involves sensory processing abnormalities. Many patients report altered sensation in the feet, including numbness, tingling, or a vague sense that the foot does not feel “connected” to the ground normally. Proprioception — the sense of where the foot is in space — can be subtly impaired, which compounds gait instability, since accurate foot-placement feedback is essential for balance correction. Some patients also experience pain syndromes localized to the foot, which can be muscular (from rigidity or cramping), dystonic, or related to peripheral neuropathy that may coexist with Parkinson’s disease, particularly in patients on long-term levodopa therapy, which has been associated in some studies with vitamin B12 deficiency and secondary neuropathy.

Autonomic and Trophic Changes

Autonomic dysfunction, another non-motor feature of Parkinson’s disease, can manifest in the feet as well. Some patients experience peripheral edema (swelling) in the lower legs and feet, which may be related to autonomic dysregulation, reduced mobility, or dopaminergic medications themselves, particularly dopamine agonists. Temperature regulation can also be affected, with some patients reporting cold, discolored feet due to changes in peripheral blood flow. Skin changes, including increased sweating or, conversely, dryness, can further affect foot health and comfort.

Functional and Practical Consequences

The cumulative effect of these changes is a foot that is harder to control, less responsive, sometimes painful, and structurally altered over time. Chronic dystonic posturing can eventually lead to fixed contractures or deformities such as hammer toes or claw toes if not managed. Footwear becomes a practical challenge, as swelling, deformity, and sensory changes all affect what shoes fit comfortably and safely. Because falls are among the most serious complications of Parkinson’s disease, addressing foot and gait dysfunction is a central goal of multidisciplinary care, often involving physical therapy focused on cueing strategies (visual or auditory cues to overcome freezing), podiatric care, orthotics, and in some cases targeted treatments such as botulinum toxin injections for painful dystonia.

Although Parkinson’s disease is often discussed in terms of tremor and overall mobility, the foot is a site of substantial and multifaceted involvement — affected by bradykinesia, rigidity, dystonia, dyskinesia, sensory disturbance, and autonomic changes alike. Understanding these foot-specific manifestations is essential not only for symptom management but for fall prevention and the preservation of independence and quality of life in people living with Parkinson’s disease.